— Know what they know.
Not Investment Advice

MPXOF OTC

MPX International Corp.
1W: -99.0% 1M: -99.0% 3M: -99.0% YTD: -99.0% 1Y: -99.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 50 · $14432 mcap · 3M float · 0.0042% daily turnover · Short 25% of daily vol

Income Trends

Revenue
$7M +127.4% ▲
3Y CAGR: +381.9%
Gross Profit
$5M +100.1% ▲
3Y CAGR: +379.1%
Operating Income
-$15M +9.2% ▲
Net Income
-$27M +35.1% ▲
EPS (Diluted)
$-0.19 +34.5% ▲
EBITDA
-$16M +55.6% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021
Revenue$64K$2M$3M$7M
YoY Growth+0.0%+2369.4%+99.3%+127.4%
Cost of Revenue$23K$4.6B$8.6B$3M
Gross Profit$41K-$4.6B-$8.6B$5M
Gross Margin64.0%-288039.7%-269637.2%62.9%
R&D Expenses$0$0$0$0
SG&A Expenses$1M$12M$14M$13M
Operating Expenses$2M$15M$18M$19M
Operating Income-$2M-$9M-$16M-$15M
Operating Margin-3234.8%-558.8%-505.5%-202.0%
Interest Expense$189$304K$885K$4M
Income Before Tax-$2M-$9M-$42M-$26M
Tax Expense$0$258K-$687K$232K
Net Income-$2M-$9M-$41M-$27M
Net Margin-3266.4%-589.3%-1294.2%-369.4%
EPS (Diluted)$-0.05$-0.13$-0.29$-0.19
EBITDA-$2M-$6M-$36M-$16M
Shares Outstanding45M72M140M143M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms